Macrogen Inc - Asset Resilience Ratio

Latest as of September 2025: 3.56%

Macrogen Inc (038290) has an Asset Resilience Ratio of 3.56% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Macrogen Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets

₩12.17 Billion
≈ $8.25 Million USD Cash + Short-term Investments

Total Assets

₩341.60 Billion
≈ $231.50 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Macrogen Inc's Asset Resilience Ratio has changed over time. See 038290 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Macrogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Macrogen Inc.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩12.17 Billion 3.56%
Total Liquid Assets ₩12.17 Billion 3.56%

Asset Resilience Insights

  • Limited Liquidity: Macrogen Inc maintains only 3.56% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Macrogen Inc Industry Peers by Asset Resilience Ratio

Compare Macrogen Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Pluristem
TA:PSTI
Biotechnology & Medical Research 48.26%
Hadasit Bio
TA:HDST
Biotechnology & Medical Research 57.00%
Purple Biotech Ltd
TA:KTOV
Biotechnology & Medical Research 0.01%
Peptron Inc
KQ:087010
Biotechnology & Medical Research 57.41%
MEDIPOST Co. Ltd
KQ:078160
Biotechnology & Medical Research 0.72%
Bioneer Corporation
KQ:064550
Biotechnology & Medical Research 14.92%
Cell Biotech Co. Ltd
KQ:049960
Biotechnology & Medical Research 54.84%
Panagene Inc
KQ:046210
Biotechnology & Medical Research 0.14%

Annual Asset Resilience Ratio for Macrogen Inc (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Macrogen Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 12.93% ₩42.62 Billion
≈ $28.88 Million
₩329.66 Billion
≈ $223.41 Million
+3.11pp
2023-12-31 9.82% ₩25.31 Billion
≈ $17.15 Million
₩257.82 Billion
≈ $174.72 Million
-7.30pp
2022-12-31 17.12% ₩47.95 Billion
≈ $32.49 Million
₩280.13 Billion
≈ $189.84 Million
-3.08pp
2021-12-31 20.20% ₩60.84 Billion
≈ $41.23 Million
₩301.18 Billion
≈ $204.10 Million
+0.35pp
2020-12-31 19.85% ₩57.12 Billion
≈ $38.71 Million
₩287.79 Billion
≈ $195.03 Million
-4.98pp
2019-12-31 24.83% ₩56.00 Billion
≈ $37.95 Million
₩225.53 Billion
≈ $152.84 Million
-21.03pp
2018-12-31 45.86% ₩82.31 Billion
≈ $55.78 Million
₩179.50 Billion
≈ $121.64 Million
-0.95pp
2017-12-31 46.80% ₩83.64 Billion
≈ $56.68 Million
₩178.71 Billion
≈ $121.11 Million
+9.77pp
2016-12-31 37.03% ₩59.07 Billion
≈ $40.03 Million
₩159.52 Billion
≈ $108.11 Million
+8.74pp
2015-12-31 28.29% ₩38.00 Billion
≈ $25.75 Million
₩134.31 Billion
≈ $91.02 Million
-9.32pp
2014-12-31 37.62% ₩43.70 Billion
≈ $29.62 Million
₩116.18 Billion
≈ $78.73 Million
+6.83pp
2013-12-31 30.78% ₩27.00 Billion
≈ $18.30 Million
₩87.71 Billion
≈ $59.44 Million
-2.10pp
2012-12-31 32.88% ₩27.00 Billion
≈ $18.30 Million
₩82.12 Billion
≈ $55.65 Million
+4.31pp
2011-12-31 28.58% ₩16.50 Billion
≈ $11.19 Million
₩57.75 Billion
≈ $39.14 Million
--
pp = percentage points

About Macrogen Inc

KQ:038290 Korea Biotechnology & Medical Research
Market Cap
$110.15 Million
₩162.55 Billion KRW
Market Cap Rank
#18805 Global
#982 in Korea
Share Price
₩16220.00
Change (1 day)
-1.34%
52-Week Range
₩14820.00 - ₩19520.00
All Time High
₩49726.89
About

Macrogen, Inc. provides genetic and genomic analysis research services in South Korea and internationally. It offers next generation sequencing (NGS) services, such as whole genome, exome, targeted, transcriptome, metagenome, epigenome, and single cell multi-omics sequencing, as well as whole genome resequencing; and standard, difficult template, and 16S/18S/26S rRNA and ITS region sequencing ser… Read more